• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Anaïs Briot, Céline Deraison, +5 authors Alain Hovnanian
  • Medicine, Biology
  • The Journal of experimental medicine
  • 2009 (First Publication: 11 May 2009)
  • Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) gene, which encodes theExpand
    Abstract When administered in artificial diets, the cysteine protease inhibitor (PI) oryzacystatin I (OC-I) induced moderate but significant growth inhibition on the pea aphid ( Acyrthosiphon pisumExpand
  • Akemi Ishida-Yamamoto, Céline Deraison, +12 authors Alain Hovnanian
  • Medicine, Biology
  • The Journal of investigative dermatology
  • 2005 (First Publication: 1 February 2005)
  • Lympho-epithelial Kazal-type-related inhibitor (LEKTI) is a putative serine protease inhibitor encoded by serine protease inhibitor Kazal-type 5 (SPINK5). It is strongly expressed in differentiatedExpand
  • C Bonnart, Céline Deraison, +9 authors Alain Hovnanian
  • Biology, Medicine
  • The Journal of clinical investigation
  • 2010 (First Publication: 1 March 2010)
  • The human epidermis serves 2 crucial barrier functions: it protects against water loss and prevents penetration of infectious agents and allergens. The physiology of the epidermis is maintained by aExpand
  • Anaïs Briot, Matthieu Lacroix, Aurelie A. Robin, Martin Steinhoff, Céline Deraison, Alain Hovnanian
  • Medicine, Biology
  • The Journal of investigative dermatology
  • 2010 (First Publication: 1 December 2010)
  • Netherton syndrome (NS) is a severe genodermatosis characterized by abnormal scaling and constant atopic manifestations. NS is caused by mutations in SPINK5 (Serine Protease INhibitor Kazal-type 5),Expand